Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The NMDAr antagonist ketamine interferes with manipulation of information for transitive inference reasoning in non-human primates.

Brunamonti E, Mione V, Di Bello F, De Luna P, Genovesio A, Ferraina S.

J Psychopharmacol. 2014 Sep;28(9):881-7. doi: 10.1177/0269881114538543. Epub 2014 Jun 18.

PMID:
24944084
2.
3.
4.

Selective cognitive impairments associated with NMDA receptor blockade in humans.

Rowland LM, Astur RS, Jung RE, Bustillo JR, Lauriello J, Yeo RA.

Neuropsychopharmacology. 2005 Mar;30(3):633-9.

5.

N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.

Skoblenick K, Everling S.

J Cogn Neurosci. 2014 Mar;26(3):577-92. doi: 10.1162/jocn_a_00519. Epub 2013 Nov 4.

PMID:
24188365
6.

Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).

Vivian JA, Waters CA, Szeliga KT, Jordan K, Grant KA.

Psychopharmacology (Berl). 2002 Jul;162(3):273-81. Epub 2002 May 14.

PMID:
12122485
7.

Neuronal Modulation in the Prefrontal Cortex in a Transitive Inference Task: Evidence of Neuronal Correlates of Mental Schema Management.

Brunamonti E, Mione V, Di Bello F, Pani P, Genovesio A, Ferraina S.

J Neurosci. 2016 Jan 27;36(4):1223-36. doi: 10.1523/JNEUROSCI.1473-15.2016.

8.

Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates.

Shiigi Y, Casey DE.

Psychopharmacology (Berl). 1999 Sep 1;146(1):67-72.

PMID:
10485966
9.

Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates I.

Popke EJ, Allen RR, Pearson EC, Hammond TG, Paule MG.

Neurotoxicol Teratol. 2001 Jul-Aug;23(4):319-32.

PMID:
11485835
10.

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A.

Neuropsychopharmacology. 1996 May;14(5):301-7.

11.

Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH.

Arch Gen Psychiatry. 2000 Mar;57(3):270-6.

PMID:
10711913
13.

Ketamine prevents stress-induced cognitive inflexibility in rats.

Nikiforuk A, Popik P.

Psychoneuroendocrinology. 2014 Feb;40:119-22. doi: 10.1016/j.psyneuen.2013.11.009. Epub 2013 Nov 20.

PMID:
24485483
14.

Cognitive mechanisms of transitive inference.

Acuna BD, Sanes JN, Donoghue JP.

Exp Brain Res. 2002 Sep;146(1):1-10. Epub 2002 May 28. Erratum in: Exp Brain Res 2002 Sep;146(1):128.

PMID:
12192572
15.

Differential muscarinic and NMDA contributions to visuo-spatial paired-associate learning in rhesus monkeys.

Taffe MA, Weed MR, Gutierrez T, Davis SA, Gold LH.

Psychopharmacology (Berl). 2002 Mar;160(3):253-62. Epub 2002 Jan 22.

16.

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW.

Neuropsychopharmacology. 1999 Feb;20(2):106-18.

17.

Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains.

Weed MR, Bookbinder M, Polino J, Keavy D, Cardinal RN, Simmermacher-Mayer J, Cometa FN, King D, Thangathirupathy S, Macor JE, Bristow LJ.

Neuropsychopharmacology. 2016 Jan;41(2):568-77. doi: 10.1038/npp.2015.184. Epub 2015 Jun 24.

18.

[Effects of a subanaesthetic dose of ketamine on emotional and behavioral state in healthy subjects].

Micallef J, Tardieu S, Gentile S, Fakra E, Jouve E, Sambuc R, Blin O.

Neurophysiol Clin. 2003 Jun;33(3):138-47. French.

PMID:
12909392
19.

Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys.

Sun L, Li Q, Li Q, Zhang Y, Liu D, Jiang H, Pan F, Yew DT.

Addict Biol. 2014 Mar;19(2):185-94. doi: 10.1111/adb.12004. Epub 2012 Nov 12.

PMID:
23145560
20.

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A.

Neuropsychopharmacology. 1997 Sep;17(3):141-50.

Supplemental Content

Support Center